TORONTO, March 2, 2016 /CNW/ - Bedrocan Canada,
wholly-owned subsidiary of Canopy Growth Corporation (Canopy
Growth) (TSXV:CGC) today continued its commitment to affordable
medical cannabis treatment by offering vaporizers at cost. The
offer, available to all registered Bedrocan Canada clients, is a
part of a wider effort to reduce the cost of medicating with
cannabis.
"Bedrocan is fully engaged with the medical community and
respects the concern many physicians have with inhaling burnt plant
matter as a means to medicate," said Marc
Wayne, Bedrocan Canada's President. "Offering deep discounts
on vaporizers is a way to address this concern by making
alternative therapy applications more affordable."
Bedrocan Canada already offers the most affordable full line of
standardized cannabis varieties in the country. Via True
Compassionate Pricing, all Bedrocan varieties cost $5 per gram for all registered clients.
"Bedrocan Canada is and will always be a medical cannabis
company," said Bruce Linton, CEO of
Canopy Growth. "Canada's cannabis
laws are evolving but Bedrocan Canada is focused on advancements on
the medical side of the industry. By advocating for tax amendments,
coordinating research initiatives and facilitating physician
education, the team at Bedrocan Canada remains focused on its core
business."
To learn more about Bedrocan Canada's vaporizer selection and
pricing, visit www.bedrocan.ca
About Bedrocan Canada
Bedrocan Canada is focused on medicinal cannabis production and
research, including, the EQUAL Study, which is currently enrolling
patients and evaluating how cannabis is affecting their quality of
life of Canadian patients. Bedrocan's standardized strains have
been used by tens of thousands of patients in seven countries
around the world. www.bedrocan.ca
About Canopy Growth Corporation
Canopy Growth is Canada's first publicly traded medical
marijuana company and the first geographically diversified producer
with multiple licenses under the Marihuana for Medical Purposes
Regulations. Through its wholly owned subsidiaries, Tweed, Tweed
Farms, and Bedrocan Canada, the Company operates three
state-of-the-art production facilities in Ontario and
distributes marijuana across the country to Canadian patients
managing a host of medical conditions. The Company is dedicated to
educating healthcare practitioners, providing consistent access to
high quality medication, conducting robust clinical research, and
furthering the public's understanding of how marijuana is used for
medical purposes. www.canopygrowth.com
Forward Looking Statement:
This news release contains forward-looking statements. Often,
but not always, forward-looking statements can be identified by the
use of words such as "plans", "expects" or "does not expect", "is
expected", "estimates", "intends", "anticipates" or "does not
anticipate", or "believes", or variations of such words and phrases
or state that certain actions, events or results "may", "could",
"would", "might" or "will" be taken, occur or be achieved.
Forward-looking statements involve known and unknown risks,
uncertainties and other factors which may cause the actual results,
performance or achievements of the Company or any of its
subsidiaries to be materially different from any future results,
performance or achievements expressed or implied by the
forward-looking statements.
Although Canopy Growth Corporation has attempted to identify
important factors that could cause actual actions, events or
results to differ materially from those described in
forward-looking statements, there may be other factors that cause
actions, events or results not to be as anticipated, estimated or
intended. Readers should not place undue reliance on
forward-looking statements. The factors identified above are not
intended to represent a complete list of the factors that could
affect the Company or any of its subsidiaries. The forward-looking
statements included in this news release are made as of the date of
this news release and Canopy Growth Corporation does not undertake
an obligation to publicly update such forward-looking statements to
reflect new information, subsequent events or otherwise unless
required by applicable securities legislation.
SOURCE Canopy Growth Corporation